MedPath

Metabolic syndrome in vitiligo

Not Applicable
Conditions
Health Condition 1: L80- Vitiligo
Registration Number
CTRI/2021/02/031393
Lead Sponsor
GSL Medical College and General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients who are diagnosed with vitiligo attending during study period will be included.

Comparison group includes patients with non-vitiligo and with conditions which are not known to be associated with metabolic syndrome and should be appropriately matched for age and sex will be included.

Exclusion Criteria

Women who are pregnant and lactating.

Patients who are using systemic treatment for last 3 months.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
This study will give information about prevalence and risk factors of metabolic syndrome in vitiligo patients and relation of metabolic syndrome to severity,duration and progression of vitiligoTimepoint: 18months
Secondary Outcome Measures
NameTimeMethod
This study will help in estimation of association of vitiligo with metabolic syndromeTimepoint: 18months
© Copyright 2025. All Rights Reserved by MedPath